Skip to main content

Advertisement

SpringerLink
Log in

Methotrexate treatment for giant cell arteritis

  • Clinical Trials Report
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jover JA, Hernandez-Garcia C, Morado IC, et al.: Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001, 134:106–114.

    PubMed  CAS  Google Scholar 

  2. Cantini F, Niccoli L, Salvarani C, et al.: Treatment of longstanding active giant cell arteritis with infliximab: report of 4 cases. Arthritis Rheum 2001, 44:2933–2935.

    Article  PubMed  CAS  Google Scholar 

  3. Salvarani C, Cantini F, Niccoli L, et al.: Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study. J Rheumatol 2003, 30:760–763.

    PubMed  Google Scholar 

Download references

Authors
  1. Luis R. Espinoza MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Espinoza, L.R. Methotrexate treatment for giant cell arteritis. Curr Rheumatol Rep 6, 181–183 (2004). https://doi.org/10.1007/s11926-004-0066-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-004-0066-4

Keywords

Search

Navigation